Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2009

01-09-2009 | Original Paper

A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure

Authors: Petra Willems, Kim De Ruyck, Rudy Van den Broecke, Amin Makar, Gianpaolo Perletti, Hubert Thierens, Anne Vral

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2009

Login to get access

Abstract

Purpose

Polymorphisms in double strand break repair genes could be involved in genetic breast cancer predisposition as enhanced chromosomal radiosensitivity is a hallmark for breast cancer. Previously, the c.-1310 C>G SNP, located in the Ku70 promoter, showed a significant odds ratio (OR) of 1.85 (P = 0.048) in sporadic, but not familial breast cancer patients, indicating that other factors besides genetic aptitude influence this association. As breast epithelium is exposed to endogenous oxidative stress through oestrogen exposure, the influence of hormone exposure was further examined.

Methods and results

A significant OR (1.69, P = 0.017) was found for an enlarged patient population through PCR-RFLP assays in a case–control study in a Belgian population. After dividing the patient population according to oestrogen exposure, high and significant ORs were seen for patients with a longer oestrogen exposure (late age at menopause: OR = 1.96, P = 0.029).

Conclusion

These results show that the variant allele of c.-1310 C>G, located in the Ku70 promoter, is a risk allele for breast cancer. Furthermore, the association of the c.-1310 C>G SNP with breast cancer risk was stronger in women with a long oestrogen exposure.
Literature
go back to reference Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A (2002) Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87:1379–1385. doi:10.1038/sj.bjc.6600628 PubMedCrossRef Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A (2002) Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87:1379–1385. doi:10.​1038/​sj.​bjc.​6600628 PubMedCrossRef
go back to reference Baeyens A, Van Den Broecke R, Makar A, Thierens H, De Ridder L, Vral A (2005) Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease. Oncol Rep 13:347–353PubMed Baeyens A, Van Den Broecke R, Makar A, Thierens H, De Ridder L, Vral A (2005) Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease. Oncol Rep 13:347–353PubMed
go back to reference Cheng T, Chen S, Huang C, Fu Y, Yu J, Cheng C, Wu P, Shen C (2005) Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113:345–353. doi:10.1002/ijc.20630 PubMedCrossRef Cheng T, Chen S, Huang C, Fu Y, Yu J, Cheng C, Wu P, Shen C (2005) Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113:345–353. doi:10.​1002/​ijc.​20630 PubMedCrossRef
go back to reference Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843–854PubMed Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843–854PubMed
go back to reference Fu Y, Yu J, Cheng T, Lou M, Hsu G, Wu C, Chen S, Wu H, Wu P, Shen C (2003) Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 63:2440–2446PubMed Fu Y, Yu J, Cheng T, Lou M, Hsu G, Wu C, Chen S, Wu H, Wu P, Shen C (2003) Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 63:2440–2446PubMed
go back to reference Gullo C, Au M, Feng G, Teoh G (2006) The biology of Ku and its potential oncogenic role in cancer. Biochim Biophys Acta 1765:223–234PubMed Gullo C, Au M, Feng G, Teoh G (2006) The biology of Ku and its potential oncogenic role in cancer. Biochim Biophys Acta 1765:223–234PubMed
go back to reference Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, Nagawa H, Suzuki N (2004) Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25:461–468PubMed Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, Nagawa H, Suzuki N (2004) Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25:461–468PubMed
go back to reference Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, Wu W, Guan J, Terdouzi G, Pantelias G (2004) Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 104:14–20. doi:10.1159/000077461 PubMedCrossRef Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, Wu W, Guan J, Terdouzi G, Pantelias G (2004) Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 104:14–20. doi:10.​1159/​000077461 PubMedCrossRef
go back to reference Jones L, Scott D, Cowan R, Roberts S (1995) Abnormal radiosensitivity of lymphocytes from breast-cancer patients with excessive normal tissue-damage after radiotherapy—chromosome-aberrations after low dose-rate irradiation. Int J Radiat Biol 67:519–528. doi:10.1080/09553009514550631 PubMedCrossRef Jones L, Scott D, Cowan R, Roberts S (1995) Abnormal radiosensitivity of lymphocytes from breast-cancer patients with excessive normal tissue-damage after radiotherapy—chromosome-aberrations after low dose-rate irradiation. Int J Radiat Biol 67:519–528. doi:10.​1080/​0955300951455063​1 PubMedCrossRef
go back to reference Kennedy R, Quinn J, Mullan P, Johnston P, Harkin D (2004) Role of BRCA1 in the cellular response to chemotherapy. J Natl Cancer Inst 96:1659–1668PubMedCrossRef Kennedy R, Quinn J, Mullan P, Johnston P, Harkin D (2004) Role of BRCA1 in the cellular response to chemotherapy. J Natl Cancer Inst 96:1659–1668PubMedCrossRef
go back to reference Kuschel B, Auranen A, McBride S, Novik K, Antoniou A, Lipscombe J, Day N, Easton D, Ponder B, Pharoah P, Dunning A (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399–1407. doi:10.1093/hmg/11.12.1399 PubMedCrossRef Kuschel B, Auranen A, McBride S, Novik K, Antoniou A, Lipscombe J, Day N, Easton D, Ponder B, Pharoah P, Dunning A (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399–1407. doi:10.​1093/​hmg/​11.​12.​1399 PubMedCrossRef
go back to reference Muller C, Paupert J, Monferran S, Salles B (2005) The double life of the Ku protein: facing the DNA breaks and the extracellular environment. Cell Cycle 4:438–441PubMed Muller C, Paupert J, Monferran S, Salles B (2005) The double life of the Ku protein: facing the DNA breaks and the extracellular environment. Cell Cycle 4:438–441PubMed
go back to reference Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton D, Evans C, Deacon J, Stratton M (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–949. doi:10.1093/jnci/91.11.943 PubMedCrossRef Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton D, Evans C, Deacon J, Stratton M (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–949. doi:10.​1093/​jnci/​91.​11.​943 PubMedCrossRef
go back to reference Pfeiffer P, Goedecke W, Kuhfittig-Kulle S, Obe G (2004) Pathways of DNA double-strand break repair and their impact on the prevention and formation of chromosomal aberrations. Cytogenet Genome Res 104:7–13. doi:10.1159/000077460 PubMedCrossRef Pfeiffer P, Goedecke W, Kuhfittig-Kulle S, Obe G (2004) Pathways of DNA double-strand break repair and their impact on the prevention and formation of chromosomal aberrations. Cytogenet Genome Res 104:7–13. doi:10.​1159/​000077460 PubMedCrossRef
go back to reference Pucci S, Mazzarelli P, Rabitti C, Giai M, Gallucci M, Flammia G, Alcini A, Altomare V, Fazio V (2001) Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene 20:739–747. doi:10.1038/sj.onc.1204148 PubMedCrossRef Pucci S, Mazzarelli P, Rabitti C, Giai M, Gallucci M, Flammia G, Alcini A, Altomare V, Fazio V (2001) Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene 20:739–747. doi:10.​1038/​sj.​onc.​1204148 PubMedCrossRef
go back to reference Roy D, Cai Q, Felty Q, Narayan S (2007) Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev 10:235–257. doi:10.1080/15287390600974924 PubMed Roy D, Cai Q, Felty Q, Narayan S (2007) Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev 10:235–257. doi:10.​1080/​1528739060097492​4 PubMed
go back to reference Rozenblum E, Vahteristo P, Sandberg T, Bergthorsson J, Syrjakoski K, Weaver D, Haraldsson K, Johannsdottir H, Vehmanen P, Nigam S, Golberger N, Robbins C, Pak E, Dutra A, Gillander E, Stephan D, Bailey-Wilson J, Juo S, Kainu T, Arason A, Barkardottir R, Nevanlinna H, Borg A, Kallioniemi O (2002) A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes. Hum Genet 110:111–121. doi:10.1007/s00439-001-0646-6 PubMedCrossRef Rozenblum E, Vahteristo P, Sandberg T, Bergthorsson J, Syrjakoski K, Weaver D, Haraldsson K, Johannsdottir H, Vehmanen P, Nigam S, Golberger N, Robbins C, Pak E, Dutra A, Gillander E, Stephan D, Bailey-Wilson J, Juo S, Kainu T, Arason A, Barkardottir R, Nevanlinna H, Borg A, Kallioniemi O (2002) A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes. Hum Genet 110:111–121. doi:10.​1007/​s00439-001-0646-6 PubMedCrossRef
go back to reference Sang-Wook L, Kyung-Ja C, Jin-Hong P, Sang Y, Soon Y, Bong-Jae L, Sing-Bae K, Seung-Ho C, Jong H, Seong S, Eun K, Eunsil Y (2005) Expressions of Ku70 and DNA-PKCS as prognostic indicators of local control of nasopharyngeal carcinoma. Int J Radiat Oncol 62:1451–1457. doi:10.1016/j.ijrobp.2004.12.049 CrossRef Sang-Wook L, Kyung-Ja C, Jin-Hong P, Sang Y, Soon Y, Bong-Jae L, Sing-Bae K, Seung-Ho C, Jong H, Seong S, Eun K, Eunsil Y (2005) Expressions of Ku70 and DNA-PKCS as prognostic indicators of local control of nasopharyngeal carcinoma. Int J Radiat Oncol 62:1451–1457. doi:10.​1016/​j.​ijrobp.​2004.​12.​049 CrossRef
go back to reference Scott D, Barber J, Levine E, Burrill W, Roberts S (1998) Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 77:614–620PubMed Scott D, Barber J, Levine E, Burrill W, Roberts S (1998) Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 77:614–620PubMed
go back to reference Someya M, Sakata K, Matsumot Y, Tauchi H, Narimatsu H, Hareyama M (2007) Association of DNA-PK activity and radiation-induced NBS1 foci formation in lymphocytes with clinicla malignancy in breast cancer patients. Oncol Rep 18:873–878PubMed Someya M, Sakata K, Matsumot Y, Tauchi H, Narimatsu H, Hareyama M (2007) Association of DNA-PK activity and radiation-induced NBS1 foci formation in lymphocytes with clinicla malignancy in breast cancer patients. Oncol Rep 18:873–878PubMed
go back to reference Teare M, Wallace S, Harris M, Howell A, Birch J (1994) Cancer experience in the relatives of an unselected series of breast-cancer patients. Br J Cancer 70:102–111PubMed Teare M, Wallace S, Harris M, Howell A, Birch J (1994) Cancer experience in the relatives of an unselected series of breast-cancer patients. Br J Cancer 70:102–111PubMed
go back to reference Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, Van den Broecke R, Makar A, Marras E, Perletti G, Thierens H, Vral A (2008) Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosom Cancer 47:137–148PubMedCrossRef Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, Van den Broecke R, Makar A, Marras E, Perletti G, Thierens H, Vral A (2008) Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosom Cancer 47:137–148PubMedCrossRef
Metadata
Title
A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure
Authors
Petra Willems
Kim De Ruyck
Rudy Van den Broecke
Amin Makar
Gianpaolo Perletti
Hubert Thierens
Anne Vral
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2009
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-009-0556-x

Other articles of this Issue 9/2009

Journal of Cancer Research and Clinical Oncology 9/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.